Enzymotec (ENZY) Misses Q2 EPS by 2c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
UPDATE: Paulson's 13F Shows New Hertz (HTZ) Puts, Stake in Horizon Pharma (HZNP), (More...)
August 14, 2017 5:32 PM EDT(Updated - August 14, 2017 5:34 PM EDT)
Paulson & Co filed its 13F for the quarter ended June 2017. Below is a summary.
New Stakes
Albany Molecular Research, Inc. (NASDAQ: AMRI) new 314,200 share position
Apple Inc. (NASDAQ: AAPL) new 12,300 share position
Bard (C.R.) Inc. (NYSE: BCR) new 42,122 share position
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) new 349,500 share position
Blueprint Medicines (NASDAQ: BPMC) new 65,800 share position
Ctrip.com International, Ltd. (NASDAQ: CTRP) new 173,200 share position
Entellus... More
